Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.78M | 1.55M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.78M | 1.55M | -- | -- | -- |
| Cost of Revenue | 14.00K | -- | -- | -- | -- |
| Gross Profit | 1.77M | 1.55M | -- | -- | -- |
| SG&A Expenses | 50.67M | 45.58M | 40.70M | 38.47M | 36.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.06M | 63.69M | 57.23M | 55.02M | 52.15M |
| Operating Income | -65.28M | -62.14M | -57.23M | -55.02M | -52.15M |
| Income Before Tax | -68.36M | -63.06M | -58.01M | -55.53M | -51.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -68.36 | -63.06 | -58.01 | -55.53 | -51.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.36M | -63.06M | -58.01M | -55.53M | -51.93M |
| EBIT | -65.28M | -62.14M | -57.23M | -55.02M | -52.15M |
| EBITDA | -65.14M | -62.03M | -57.13M | -54.91M | -52.05M |
| EPS Basic | -0.68 | -0.80 | -0.82 | -0.84 | -0.78 |
| Normalized Basic EPS | -0.43 | -0.50 | -0.51 | -0.52 | -0.49 |
| EPS Diluted | -0.68 | -0.80 | -0.82 | -0.84 | -0.78 |
| Normalized Diluted EPS | -0.43 | -0.50 | -0.51 | -0.52 | -0.49 |
| Average Basic Shares Outstanding | 399.20M | 335.20M | 295.43M | 265.13M | 264.91M |
| Average Diluted Shares Outstanding | 399.20M | 335.20M | 295.43M | 265.13M | 264.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |